ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Mitogen-activated protein kinase (MAPK) >Raf inhibitors >RAF265(CHIR-265)

RAF265(CHIR-265)

RAF265(CHIR-265) Structure
CAS No.
927880-90-8
Chemical Name:
RAF265(CHIR-265)
Synonyms
RAF265;CS-1852;RAF265, >=98%;RAF265(CHIR-265);CHIR-265 or RAF265;RAF265 or CHIR-265;CHIR265;RAF-265;CHIR 265;;RAF265(CHIR-265) USP/EP/BP;RAF265 (CHIR-265);RAF-265; CHIR265;1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]-oxy]-N-[4-(trifluoromethyl)
CBNumber:
CB92526152
Molecular Formula:
C24H16F6N6O
Molecular Weight:
518.41
MOL File:
927880-90-8.mol
Modify Date:
2024/7/2 8:55:41

RAF265(CHIR-265) Properties

Boiling point 667.6±65.0 °C(Predicted)
Density 1.50
storage temp. Store at -20°C
solubility ≥25.9 mg/mL in DMSO; insoluble in H2O; ≥7.97 mg/mL in EtOH with ultrasonic
pka 9.07±0.27(Predicted)
form Solid
color White to khaki
Sensitive Light Sensitive

RAF265(CHIR-265) Chemical Properties,Uses,Production

Uses

RAF265 (CHIR-265) is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 μM.

Global( 116)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Capot Chemical Co.,Ltd. 571-85586718 +8613336195806 China 29798 60 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29901 58 Inquiry
Chongqing Chemdad Co., Ltd +86-023-6139-8061 +86-86-13650506873 China 39916 58 Inquiry
CONIER CHEM AND PHARMA LIMITED +8618523575427 China 49391 58 Inquiry
Dideu Industries Group Limited +86-29-89586680 +86-15129568250 China 26216 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry
InvivoChem +1-708-310-1919 +1-13798911105 United States 6393 58 Inquiry

927880-90-8(RAF265(CHIR-265))Related Search:

chevron_left

1of2

chevron_right
RAF265(CHIR-265) RAF265 CHIR-265 or RAF265 1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine 1-methyl-5-(2-(5-(trifluoromethyl)-1H-imidazol-2-yl)pyridin-4-yloxy)-N-(4-(trifluoromethyl)phenyl)-1H-benzo[d]imidazol-2-amine 1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine RAF265 (CHIR-265) RAF 265 1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine 1H-Benzimidazol-2-amine, 1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]- RAF265, >=98% 1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine RAF265 (CHIR-265);RAF-265; CHIR265 1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]-oxy]-N-[4-(trifluoromethyl) CS-1852 CHIR265;RAF-265;CHIR 265; RAF265 or CHIR-265 RAF265(CHIR-265) USP/EP/BP 927880-90-8 C24H16F6N6O MAPK Inhibitors